Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) has a beta of 1.26, a 12-month trailing P/E ratio of 59.32, and a growth ratio of 6.99. The stock’s Relative
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Relative Strength Index (RSI) is 74.86, with weekly volatility at 0.95% and ATR at 1.78. The ALXN stock’s 52-week price range
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) has a beta of 1.26, a 12-month trailing P/E ratio of 57.98, and a growth ratio of 6.83. The stock’s Relative
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) shares traded lower over the last trading session, losing -0.20% on 06/02/21. The shares fell to a low of $174.92 before
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) shares traded lower over the last trading session, losing -0.36% on 05/21/21. The shares fell to a low of $176.76 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
